{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T21:38:53Z","timestamp":1792791533664,"version":"4.5.0"},"reference-count":100,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T00:00:00Z","timestamp":1776211200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T00:00:00Z","timestamp":1776211200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Ellebedy Fellowship for Young Scientists","award":["EF3\/2024\/4."],"award-info":[{"award-number":["EF3\/2024\/4."]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Drug Deliv. and Transl. Res."],"DOI":"10.1007\/s13346-026-02116-7","type":"journal-article","created":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T13:38:30Z","timestamp":1776260310000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["A dual-function rebamipide cubogel for enhanced ocular penetration and tear film restoration: optimization, safety, and in-vivo evaluation"],"prefix":"10.1007","author":[{"ORCID":"https:\/\/orcid.org\/0009-0005-7187-3161","authenticated-orcid":false,"given":"Mayar","family":"Salama","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0347-0513","authenticated-orcid":false,"given":"Islam M.","family":"Adel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Randa","family":"Tag","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed R.","family":"Fares","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,15]]},"reference":[{"key":"2116_CR1","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1016\/j.jconrel.2023.01.018","volume":"354","author":"AL Onugwu","year":"2023","unstructured":"Onugwu AL, Nwagwu CS, Onugwu OS, Echezona AC, Agbo CP, Ihim SA, et al. Nanotechnology based drug delivery systems for the treatment of anterior segment eye diseases. J Control Release. 2023;354:465\u201388. https:\/\/doi.org\/10.1016\/j.jconrel.2023.01.018.","journal-title":"J Control Release"},{"issue":"6","key":"2116_CR2","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1177\/08853282251369229","volume":"40","author":"NE Subhash","year":"2026","unstructured":"Subhash NE, Prabhu M, Hazarika M, S S, Bhandary SV, Guru BR. Advances in the management of ocular anterior segment diseases using biomaterials-based drug delivery systems. J Biomater Appl. 2026;40(6):666\u201389. https:\/\/doi.org\/10.1177\/08853282251369229.","journal-title":"J Biomater Appl"},{"key":"2116_CR3","doi-asserted-by":"publisher","DOI":"10.3389\/fmolb.2024.1421959","volume":"11","author":"MS Baig","year":"2024","unstructured":"Baig MS, Karade SK, Ahmad A, Khan MA, Haque A, Webster TJ, et al. Lipid-based nanoparticles: innovations in ocular drug delivery. Front Mol Biosci. 2024;11:1421959. https:\/\/doi.org\/10.3389\/fmolb.2024.1421959.","journal-title":"Front Mol Biosci"},{"key":"2116_CR4","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics10010028","author":"RD Bachu","year":"2018","unstructured":"Bachu RD, Chowdhury P, Al-Saedi ZHF, Karla PK, Boddu SHS. Ocular drug delivery barriers-role of nanocarriers in the treatment of anterior segment ocular diseases. Pharmaceutics. 2018. https:\/\/doi.org\/10.3390\/pharmaceutics10010028.","journal-title":"Pharmaceutics"},{"key":"2116_CR5","doi-asserted-by":"publisher","first-page":"4045","DOI":"10.2147\/IJN.S456613","volume":"19","author":"W Wei","year":"2024","unstructured":"Wei W, Cao H, Shen D, Sun X, Jia Z, Zhang M. Antioxidant carbon dots nanozyme loaded in thermosensitive in situ hydrogel system for efficient dry eye disease treatment. Int J Nanomedicine. 2024;19:4045\u201360. https:\/\/doi.org\/10.2147\/IJN.S456613.","journal-title":"Int J Nanomedicine"},{"key":"2116_CR6","doi-asserted-by":"publisher","DOI":"10.1016\/j.pmatsci.2025.101634","author":"S Ghosh","year":"2026","unstructured":"Ghosh S, Yang C-J, Lai J-Y. Hollow nanoarchitectures: materials engineering, nanochemistry, and biomedical applications. Prog Mater Sci. 2026. https:\/\/doi.org\/10.1016\/j.pmatsci.2025.101634.","journal-title":"Prog Mater Sci"},{"issue":"3","key":"2116_CR7","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1016\/j.jtos.2017.05.003","volume":"15","author":"F Stapleton","year":"2017","unstructured":"Stapleton F, Alves M, Bunya VY, Jalbert I, Lekhanont K, Malet F, et al. TFOS DEWS II epidemiology report. Ocul Surf. 2017;15(3):334\u201365. https:\/\/doi.org\/10.1016\/j.jtos.2017.05.003.","journal-title":"Ocul Surf"},{"key":"2116_CR8","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.ajo.2025.09.035","volume":"282","author":"VL Perez","year":"2025","unstructured":"Perez VL, Chen W, Craig JP, Dogru M, Jones L, Stapleton F, et al. TFOS DEWS III: executive summary. Am J Ophthalmol. 2025;282:135\u201345. https:\/\/doi.org\/10.1016\/j.ajo.2025.09.035.","journal-title":"Am J Ophthalmol"},{"key":"2116_CR9","doi-asserted-by":"publisher","DOI":"10.1016\/j.exer.2020.108115","volume":"197","author":"SC Pflugfelder","year":"2020","unstructured":"Pflugfelder SC, Stern ME. Biological functions of tear film. Exp Eye Res. 2020;197:108115. https:\/\/doi.org\/10.1016\/j.exer.2020.108115.","journal-title":"Exp Eye Res"},{"issue":"3","key":"2116_CR10","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1016\/j.jtos.2017.05.008","volume":"15","author":"JP Craig","year":"2017","unstructured":"Craig JP, Nichols KK, Akpek EK, Caffery B, Dua HS, Joo CK, et al. TFOS DEWS II definition and classification report. Ocul Surf. 2017;15(3):276\u201383. https:\/\/doi.org\/10.1016\/j.jtos.2017.05.008.","journal-title":"Ocul Surf"},{"key":"2116_CR11","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2025.125355","volume":"672","author":"R Baghban","year":"2025","unstructured":"Baghban R, Bamdad S, Attar A, Mortazavi M. Implications of nanotechnology for the treatment of dry eye disease: recent advances. Int J Pharm. 2025;672:125355. https:\/\/doi.org\/10.1016\/j.ijpharm.2025.125355.","journal-title":"Int J Pharm"},{"key":"2116_CR12","doi-asserted-by":"publisher","DOI":"10.3390\/gels8120816","author":"Q Li","year":"2022","unstructured":"Li Q, Cao Y, Wang P. Recent advances in hydrogels for the diagnosis and treatment of dry eye disease. Gels. 2022. https:\/\/doi.org\/10.3390\/gels8120816.","journal-title":"Gels"},{"issue":"1","key":"2116_CR13","doi-asserted-by":"publisher","DOI":"10.1136\/bmjophth-2021-000709","volume":"6","author":"C Chan","year":"2021","unstructured":"Chan C, Ziai S, Myageri V, Burns JG, Prokopich CL. Economic burden and loss of quality of life from dry eye disease in Canada. BMJ Open Ophthalmol. 2021;6(1):e000709. https:\/\/doi.org\/10.1136\/bmjophth-2021-000709.","journal-title":"BMJ Open Ophthalmol"},{"key":"2116_CR14","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.jtos.2021.05.006","volume":"21","author":"MK Morthen","year":"2021","unstructured":"Morthen MK, Magno MS, Utheim TP, Snieder H, Hammond CJ, Vehof J. The physical and mental burden of dry eye disease: a large population-based study investigating the relationship with health-related quality of life and its determinants. Ocul Surf. 2021;21:107\u201317. https:\/\/doi.org\/10.1016\/j.jtos.2021.05.006.","journal-title":"Ocul Surf"},{"key":"2116_CR15","doi-asserted-by":"publisher","DOI":"10.1016\/j.jddst.2022.103654","author":"H Qiao","year":"2022","unstructured":"Qiao H, Xu Z, Sun M, Fu S, Zhao F, Wang D, et al. Rebamipide liposome as an effective ocular delivery system for the management of dry eye disease. J Drug Deliv Sci Technol. 2022. https:\/\/doi.org\/10.1016\/j.jddst.2022.103654.","journal-title":"J Drug Deliv Sci Technol"},{"key":"2116_CR16","doi-asserted-by":"publisher","DOI":"10.3390\/ijms26083922","author":"B Bhujel","year":"2025","unstructured":"Bhujel B, Oh SH, Hur W, Lee S, Lee H, Chung HS, et al. Rebamipide enhances pathogen defense and mitigates inflammation in a particulate matter-induced ocular surface inflammation rat model. Int J Mol Sci. 2025. https:\/\/doi.org\/10.3390\/ijms26083922.","journal-title":"Int J Mol Sci"},{"issue":"2","key":"2116_CR17","doi-asserted-by":"publisher","DOI":"10.1208\/s12249-023-02516-9","volume":"24","author":"S Ahmed","year":"2023","unstructured":"Ahmed S, Amin MM, Sayed S. Ocular drug delivery: a comprehensive review. AAPS PharmSciTech. 2023;24(2):66. https:\/\/doi.org\/10.1208\/s12249-023-02516-9.","journal-title":"AAPS PharmSciTech"},{"issue":"3","key":"2116_CR18","doi-asserted-by":"publisher","first-page":"207","DOI":"10.4103\/ojo.OJO_29_2017","volume":"11","author":"S Shrivastava","year":"2018","unstructured":"Shrivastava S, Patkar P, Ramakrishnan R, Kanhere M, Riaz Z. Efficacy of rebamipide 2% ophthalmic solution in the treatment of dry eyes. Oman J Ophthalmol. 2018;11(3):207\u201312. https:\/\/doi.org\/10.4103\/ojo.OJO_29_2017.","journal-title":"Oman J Ophthalmol"},{"issue":"6","key":"2116_CR19","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1089\/jop.2018.0130","volume":"35","author":"C Simsek","year":"2019","unstructured":"Simsek C, Dogru M, Shinzawa M, Den S, Kojima T, Iseda H, et al. The efficacy of 2% topical rebamipide on conjunctival squamous metaplasia and goblet cell density in dry eye disease. J Ocul Pharmacol Ther. 2019;35(6):350\u20138. https:\/\/doi.org\/10.1089\/jop.2018.0130.","journal-title":"J Ocul Pharmacol Ther"},{"key":"2116_CR20","doi-asserted-by":"publisher","DOI":"10.1016\/j.exer.2021.108824","volume":"213","author":"Q Li","year":"2021","unstructured":"Li Q, Wu X, Xin M. Strengthened rebamipide ocular nanoformulation to effectively treat corneal alkali burns in mice through the HMGB1 signaling pathway. Exp Eye Res. 2021;213:108824. https:\/\/doi.org\/10.1016\/j.exer.2021.108824.","journal-title":"Exp Eye Res"},{"key":"2116_CR21","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics12020155","author":"N Nagai","year":"2020","unstructured":"Nagai N, Ishii M, Seiriki R, Ogata F, Otake H, Nakazawa Y, et al. Novel sustained-release drug delivery system for dry eye therapy by rebamipide nanoparticles. Pharmaceutics. 2020. https:\/\/doi.org\/10.3390\/pharmaceutics12020155.","journal-title":"Pharmaceutics"},{"key":"2116_CR22","doi-asserted-by":"publisher","DOI":"10.1016\/j.jct.2019.106045","author":"W Li","year":"2020","unstructured":"Li W, Farajtabar A, Xing R, Zhu Y, Zhao H, Lv R. Thermodynamic solubility, solvent effect and preferential solvation analysis of rebamipide in aqueous co-solvent mixtures of propylene glycol, n-propanol, isopropanol and ethanol. J Chem Thermodyn. 2020. https:\/\/doi.org\/10.1016\/j.jct.2019.106045.","journal-title":"J Chem Thermodyn"},{"key":"2116_CR23","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines11041114","author":"D Sivadasan","year":"2023","unstructured":"Sivadasan D, Sultan MH, Alqahtani SS, Javed S. Cubosomes in drug delivery-a comprehensive review on its structural components, preparation techniques and therapeutic applications. Biomedicines. 2023. https:\/\/doi.org\/10.3390\/biomedicines11041114.","journal-title":"Biomedicines"},{"issue":"15","key":"2116_CR24","doi-asserted-by":"publisher","first-page":"2781","DOI":"10.1039\/d2tb00031h","volume":"10","author":"MAS Abourehab","year":"2022","unstructured":"Abourehab MAS, Ansari MJ, Singh A, Hassan A, Abdelgawad MA, Shrivastav P, et al. Cubosomes as an emerging platform for drug delivery: a review of the state of the art. J Mater Chem B. 2022;10(15):2781\u2013819. https:\/\/doi.org\/10.1039\/d2tb00031h.","journal-title":"J Mater Chem B"},{"key":"2116_CR25","doi-asserted-by":"publisher","DOI":"10.3390\/polym14153118","author":"H Umar","year":"2022","unstructured":"Umar H, Wahab HA, Gazzali AM, Tahir H, Ahmad W. Cubosomes: design, development, and tumor-targeted drug delivery applications. Polymers (Basel). 2022. https:\/\/doi.org\/10.3390\/polym14153118.","journal-title":"Polymers (Basel)"},{"key":"2116_CR26","doi-asserted-by":"publisher","DOI":"10.1016\/j.jddst.2024.105817","author":"EM Salem","year":"2024","unstructured":"Salem EM, Dawaba HM, Elbaset MA, Gad S, Hassan TH. Optimizing bioavailability and antihypertensive activity of Carvedilol cubosomes using D-optimal design: comparative analysis of Cremophor RH 40 and Polyvinyl alcohol as secondary stabilizers. J Drug Deliv Sci Technol. 2024. https:\/\/doi.org\/10.1016\/j.jddst.2024.105817.","journal-title":"J Drug Deliv Sci Technol"},{"issue":"1","key":"2116_CR27","doi-asserted-by":"publisher","DOI":"10.1080\/10717544.2022.2162162","volume":"30","author":"NA Shoman","year":"2023","unstructured":"Shoman NA, Gebreel RM, El-Nabarawi MA, Attia A. Optimization of hyaluronan-enriched cubosomes for bromfenac delivery enhancing corneal permeation: characterization, ex vivo, and in vivo evaluation. Drug Deliv. 2023;30(1):2162162. https:\/\/doi.org\/10.1080\/10717544.2022.2162162.","journal-title":"Drug Deliv"},{"issue":"5","key":"2116_CR28","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1016\/j.drudis.2016.01.004","volume":"21","author":"Z Karami","year":"2016","unstructured":"Karami Z, Hamidi M. Cubosomes: remarkable drug delivery potential. Drug Discov Today. 2016;21(5):789\u2013801. https:\/\/doi.org\/10.1016\/j.drudis.2016.01.004.","journal-title":"Drug Discov Today"},{"issue":"1","key":"2116_CR29","doi-asserted-by":"publisher","first-page":"123","DOI":"10.22270\/jddt.v10i1.3814","volume":"10","author":"P Kumar","year":"2020","unstructured":"Kumar P, Ashawat MS, Pandit V, Sharma DR, Dhadwal A. Cubosomes: a novel carrier for transdermal drug delivery. J Drug Deliv Ther. 2020;10(1):123\u201330. https:\/\/doi.org\/10.22270\/jddt.v10i1.3814.","journal-title":"J Drug Deliv Ther"},{"key":"2116_CR30","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2025.125504","volume":"675","author":"R Khadke","year":"2025","unstructured":"Khadke R, Shete A, Dashawant A. Design and development of dasatinib nanoemulsions for ocular delivery: in vitro characterization, biocompatibility, and ex vivo ocular irritation study. Int J Pharm. 2025;675:125504. https:\/\/doi.org\/10.1016\/j.ijpharm.2025.125504.","journal-title":"Int J Pharm"},{"issue":"10","key":"2116_CR31","doi-asserted-by":"publisher","DOI":"10.1007\/s11095-020-02857-1","volume":"37","author":"SA Gaballa","year":"2020","unstructured":"Gaballa SA, El Garhy OH, Moharram H, Abdelkader H. Preparation and evaluation of cubosomes\/cubosomal gels for ocular delivery of beclomethasone dipropionate for management of uveitis. Pharm Res. 2020;37(10):198. https:\/\/doi.org\/10.1007\/s11095-020-02857-1.","journal-title":"Pharm Res"},{"key":"2116_CR32","doi-asserted-by":"publisher","first-page":"1659","DOI":"10.2147\/IJN.S345430","volume":"17","author":"RA Shalaby","year":"2022","unstructured":"Shalaby RA, El-Gazayerly O, Abdallah M. Cubosomal betamethasone-salicylic acid nano drug delivery system for enhanced management of scalp psoriasis. Int J Nanomedicine. 2022;17:1659\u201377. https:\/\/doi.org\/10.2147\/IJN.S345430.","journal-title":"Int J Nanomedicine"},{"issue":"1","key":"2116_CR33","doi-asserted-by":"publisher","first-page":"4","DOI":"10.4103\/ijabmr.IJABMR_399_20","volume":"11","author":"RM Rajendraprasad","year":"2021","unstructured":"Rajendraprasad RM, Kwatra G, Batra N. Carboxymethyl cellulose versus hydroxypropyl methylcellulose tear substitutes for dry eye due to computer vision syndrome: comparison of efficacy and safety. Int J Appl Basic Med Res. 2021;11(1):4\u20138. https:\/\/doi.org\/10.4103\/ijabmr.IJABMR_399_20.","journal-title":"Int J Appl Basic Med Res"},{"key":"2116_CR34","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23052434","author":"M Labetoulle","year":"2022","unstructured":"Labetoulle M, Benitez-Del-Castillo JM, Barabino S, Herrero Vanrell R, Daull P, Garrigue JS, et al. Artificial tears: biological role of their ingredients in the management of dry eye disease. Int J Mol Sci. 2022. https:\/\/doi.org\/10.3390\/ijms23052434.","journal-title":"Int J Mol Sci"},{"issue":"1","key":"2116_CR35","doi-asserted-by":"publisher","first-page":"2","DOI":"10.4082\/kjfm.2017.38.1.2","volume":"38","author":"JK Song","year":"2017","unstructured":"Song JK, Lee K, Park HY, Hyon JY, Oh SW, Bae WK, et al. Efficacy of carboxymethylcellulose and hyaluronate in dry eye disease: a systematic review and meta-analysis. Korean J Fam Med. 2017;38(1):2\u20137. https:\/\/doi.org\/10.4082\/kjfm.2017.38.1.2.","journal-title":"Korean J Fam Med"},{"issue":"1","key":"2116_CR36","doi-asserted-by":"publisher","DOI":"10.1186\/s12886-023-03004-1","volume":"23","author":"Y Eom","year":"2023","unstructured":"Eom Y, Chung SH, Chung TY, Kim JY, Choi CY, Yoon KC, et al. Efficacy and safety of 1% and 2% rebamipide clear solution in dry eye disease: a multicenter randomized trial. BMC Ophthalmol. 2023;23(1):343. https:\/\/doi.org\/10.1186\/s12886-023-03004-1.","journal-title":"BMC Ophthalmol"},{"issue":"3","key":"2116_CR37","doi-asserted-by":"publisher","first-page":"207","DOI":"10.2174\/1567201817666200122161433","volume":"17","author":"EA Hakeem","year":"2020","unstructured":"Hakeem EA, El-Mahrouk GM, Abdelbary G, Teaima MH. Freeze-dried clopidogrel loaded lyotropic liquid crystal: box-behnken optimization, in-vitro and in-vivo evaluation. Curr Drug Deliv. 2020;17(3):207\u201317. https:\/\/doi.org\/10.2174\/1567201817666200122161433.","journal-title":"Curr Drug Deliv"},{"key":"2116_CR38","doi-asserted-by":"publisher","DOI":"10.3390\/gels8040241","author":"NA Alhakamy","year":"2022","unstructured":"Alhakamy NA, Hosny KM, Rizg WY, Eshmawi BA, Badr MY, Safhi AY, et al. Development and optimization of hyaluronic acid-poloxamer in-situ gel loaded with voriconazole cubosomes for enhancement of activity against ocular fungal infection. Gels. 2022. https:\/\/doi.org\/10.3390\/gels8040241.","journal-title":"Gels"},{"key":"2116_CR39","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2023.123530","volume":"647","author":"M Shareef Khan","year":"2023","unstructured":"Shareef Khan M, Rao Ravi P, Shrikant Dhavan D. Design, optimization and pharmacokinetic evaluation of PLGA phosphatidylcholine hybrid nanoparticles of triamcinolone acetonide loaded in situ gel for topical ocular delivery. Int J Pharm. 2023;647:123530. https:\/\/doi.org\/10.1016\/j.ijpharm.2023.123530.","journal-title":"Int J Pharm"},{"issue":"1","key":"2116_CR40","doi-asserted-by":"publisher","first-page":"1663","DOI":"10.1080\/10717544.2022.2079770","volume":"29","author":"M Zewail","year":"2022","unstructured":"Zewail M, Eg PM, Ali MM, Abbas H. Lipidic cubic-phase leflunomide nanoparticles (cubosomes) as a potential tool for breast cancer management. Drug Deliv. 2022;29(1):1663\u201374. https:\/\/doi.org\/10.1080\/10717544.2022.2079770.","journal-title":"Drug Deliv"},{"key":"2116_CR41","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2021.120490","volume":"600","author":"AM Al-Mahallawi","year":"2021","unstructured":"Al-Mahallawi AM, Abdelbary AA, El-Zahaby SA. Norfloxacin loaded nano-cubosomes for enhanced management of otitis externa: in vitro and in vivo evaluation. Int J Pharm. 2021;600:120490. https:\/\/doi.org\/10.1016\/j.ijpharm.2021.120490.","journal-title":"Int J Pharm"},{"issue":"1\u20132","key":"2116_CR42","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1016\/j.ijpharm.2018.10.057","volume":"553","author":"NF Younes","year":"2018","unstructured":"Younes NF, Abdel-Halim SA, Elassasy AI. Corneal targeted sertaconazole nitrate loaded cubosomes: preparation, statistical optimization, in vitro characterization, ex vivo permeation and in vivo studies. Int J Pharm. 2018;553(1\u20132):386\u201397. https:\/\/doi.org\/10.1016\/j.ijpharm.2018.10.057.","journal-title":"Int J Pharm"},{"key":"2116_CR43","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1016\/j.jddst.2019.04.036","volume":"52","author":"AE Eldeeb","year":"2019","unstructured":"Eldeeb AE, Salah S, Ghorab M. Formulation and evaluation of cubosomes drug delivery system for treatment of glaucoma: ex-vivo permeation and in-vivo pharmacodynamic study. J Drug Deliv Sci Technol. 2019;52:236\u201347. https:\/\/doi.org\/10.1016\/j.jddst.2019.04.036.","journal-title":"J Drug Deliv Sci Technol"},{"key":"2116_CR44","doi-asserted-by":"publisher","DOI":"10.3390\/ph18030421","author":"K Zarif Attalla","year":"2025","unstructured":"Zarif Attalla K, Hassan DH, Teaima MH, Yousry C, El-Nabarawi MA, Said MA, et al. Enhanced intranasal delivery of atorvastatin via superparamagnetic iron-oxide-loaded nanocarriers: cytotoxicity and inflammation evaluation and in vivo, in silico, and network pharmacology study for targeting glioblastoma management. Pharmaceuticals (Basel). 2025. https:\/\/doi.org\/10.3390\/ph18030421.","journal-title":"Pharmaceuticals (Basel)"},{"issue":"1","key":"2116_CR45","doi-asserted-by":"publisher","DOI":"10.1080\/10717544.2022.2162159","volume":"30","author":"HA Elgendy","year":"2023","unstructured":"Elgendy HA, Makky AMA, Elakkad YE, Ismail RM, Younes NF. Syringeable atorvastatin loaded eugenol enriched PEGylated cubosomes in-situ gel for the intra-pocket treatment of periodontitis: statistical optimization and clinical assessment. Drug Deliv. 2023;30(1):2162159. https:\/\/doi.org\/10.1080\/10717544.2022.2162159.","journal-title":"Drug Deliv"},{"key":"2116_CR46","doi-asserted-by":"publisher","DOI":"10.1016\/j.jddst.2024.105886","author":"AA Nemr","year":"2024","unstructured":"Nemr AA, Ahmed S, Adel IM. Limonene-enriched ultra-structural cubosomes to augment ocular delivery of a poorly water soluble anti-fungal drug: fabrication, characterization, statistical optimization, in vivo corneal uptake and histopathological evaluation in rabbits. J Drug Deliv Sci Technol. 2024. https:\/\/doi.org\/10.1016\/j.jddst.2024.105886.","journal-title":"J Drug Deliv Sci Technol"},{"key":"2116_CR47","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.2147\/IJN.S337130","volume":"17","author":"D Hegazy","year":"2022","unstructured":"Hegazy D, Tag R, Habib BA. Statistical sequential experimentation: preliminary mixed factorial design, I-optimal mixture design then finally novel design space expansion for optimization of Tazarotene cubosomes. Int J Nanomedicine. 2022;17:1069\u201386. https:\/\/doi.org\/10.2147\/IJN.S337130.","journal-title":"Int J Nanomedicine"},{"issue":"1","key":"2116_CR48","doi-asserted-by":"publisher","first-page":"2428","DOI":"10.1080\/10717544.2022.2103600","volume":"29","author":"S Ahmed","year":"2022","unstructured":"Ahmed S, Amin MM, El-Korany SM, Sayed S. Corneal targeted fenticonazole nitrate-loaded novasomes for the management of ocular candidiasis: preparation, in vitro characterization, ex vivo and in vivo assessments. Drug Deliv. 2022;29(1):2428\u201341. https:\/\/doi.org\/10.1080\/10717544.2022.2103600.","journal-title":"Drug Deliv"},{"issue":"7","key":"2116_CR49","doi-asserted-by":"publisher","first-page":"2677","DOI":"10.1016\/j.xphs.2021.02.007","volume":"110","author":"AM Mohsen","year":"2021","unstructured":"Mohsen AM, Younis MM, Salama A, Darwish AB. Cubosomes as a potential oral drug delivery system for enhancing the hepatoprotective effect of coenzyme Q10. J Pharm Sci. 2021;110(7):2677\u201386. https:\/\/doi.org\/10.1016\/j.xphs.2021.02.007.","journal-title":"J Pharm Sci"},{"key":"2116_CR50","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2026.126788","author":"SS Hashem","year":"2026","unstructured":"Hashem SS, Ibrahim HK, El Shaboury KF, Awad HH, El-Shiekh RA, Younes NF. Immuno-redox modulator loaded trehalosomal hydrogel for atopic dermatitis: formulation, optimization using D-optimal mixture design, in-vitro and in-vivo evaluation. Int J Pharm. 2026. https:\/\/doi.org\/10.1016\/j.ijpharm.2026.126788.","journal-title":"Int J Pharm"},{"key":"2116_CR51","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics13020221","author":"R Abdelmonem","year":"2021","unstructured":"Abdelmonem R, Elhabal SF, Abdelmalak NS, El-Nabarawi MA, Teaima MH. Formulation and characterization of acetazolamide\/carvedilol niosomal gel for glaucoma treatment: in vitro, and in vivo study. Pharmaceutics. 2021. https:\/\/doi.org\/10.3390\/pharmaceutics13020221.","journal-title":"Pharmaceutics"},{"key":"2116_CR52","doi-asserted-by":"publisher","first-page":"2667","DOI":"10.2147\/IJN.S306831","volume":"16","author":"IM Adel","year":"2021","unstructured":"Adel IM, ElMeligy MF, Abdelrahim MEA, Maged A, Abdelkhalek AA, Abdelmoteleb AMM, et al. Design and characterization of spray-dried proliposomes for the pulmonary delivery of Curcumin. Int J Nanomedicine. 2021;16:2667\u201387. https:\/\/doi.org\/10.2147\/IJN.S306831.","journal-title":"Int J Nanomedicine"},{"key":"2116_CR53","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejps.2023.106659","volume":"192","author":"IM Adel","year":"2024","unstructured":"Adel IM, ElMeligy MF, Amer MS, Elkasabgy NA. Gellan gum-based bi-polymeric hydrogel scaffolds loaded with Rosuvastatin calcium: a useful tool for tendon tissue regeneration. Eur J Pharm Sci. 2024;192:106659. https:\/\/doi.org\/10.1016\/j.ejps.2023.106659.","journal-title":"Eur J Pharm Sci"},{"issue":"1","key":"2116_CR54","doi-asserted-by":"publisher","first-page":"2945","DOI":"10.1080\/10717544.2022.2120926","volume":"29","author":"S Ahmed","year":"2022","unstructured":"Ahmed S, Amin MM, El-Korany SM, Sayed S. Pronounced capping effect of olaminosomes as nanostructured platforms in ocular candidiasis management. Drug Deliv. 2022;29(1):2945\u201358. https:\/\/doi.org\/10.1080\/10717544.2022.2120926.","journal-title":"Drug Deliv"},{"key":"2116_CR55","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics15071947","author":"A Kassem","year":"2023","unstructured":"Kassem A, Refai H, El-Nabarawi MA, Abdellatif MM. Formulation and evaluation of prednisolone sodium metazoate-loaded mucoadhesive quatsomal gel for local treatment of recurrent aphthous ulcers: optimization, in vitro, ex vivo, and in vivo studies. Pharmaceutics. 2023. https:\/\/doi.org\/10.3390\/pharmaceutics15071947.","journal-title":"Pharmaceutics"},{"key":"2116_CR56","doi-asserted-by":"publisher","unstructured":"Mouhram NA, Mosallam S, Hassan M, El-Gazar AA, El-Nabarawi MA, Fayez SM. Tailoring moxifloxacin hydrochloride loaded oleic acid liposomes for the topical management of Methicillin-Resistant Staphylococcus aureus (MRSA)- Induced skin infection: In-vitro characterization and in-vivo assessment. Int J Pharm. 2024:125115. https:\/\/doi.org\/10.1016\/j.ijpharm.2024.125115.","DOI":"10.1016\/j.ijpharm.2024.125115"},{"issue":"8","key":"2116_CR57","doi-asserted-by":"publisher","first-page":"2258","DOI":"10.1016\/j.xphs.2022.02.012","volume":"111","author":"MA Bekhet","year":"2022","unstructured":"Bekhet MA, Ali AA, Kharshoum RM, El-Ela FIA, Salem HF. Intranasal niosomal in situ gel as a novel strategy for improving citicoline efficacy and brain delivery in treatment of epilepsy: in vitro and ex vivo characterization and in vivo pharmacodynamics investigation. J Pharm Sci. 2022;111(8):2258\u201369. https:\/\/doi.org\/10.1016\/j.xphs.2022.02.012.","journal-title":"J Pharm Sci"},{"key":"2116_CR58","doi-asserted-by":"publisher","DOI":"10.3390\/molecules28114395","author":"S Suriyaprom","year":"2023","unstructured":"Suriyaprom S, Srisai P, Intachaisri V, Kaewkod T, Pekkoh J, Desvaux M, et al. Antioxidant and anti-inflammatory activity on LPS-stimulated RAW 264.7 macrophage cells of white mulberry (Morus alba L.) leaf extracts. Molecules. 2023. https:\/\/doi.org\/10.3390\/molecules28114395.","journal-title":"Molecules"},{"key":"2116_CR59","doi-asserted-by":"publisher","DOI":"10.3390\/microorganisms12071306","author":"YW Chang","year":"2024","unstructured":"Chang YW, Sun YL, Chu E, Hung YY, Liao WC, Tsai SM, et al. Streptococcus thermophilus iHA318 improves dry eye symptoms by mitigating ocular surface damage in a mouse model. Microorganisms. 2024. https:\/\/doi.org\/10.3390\/microorganisms12071306.","journal-title":"Microorganisms"},{"key":"2116_CR60","doi-asserted-by":"publisher","DOI":"10.3390\/molecules29225327","author":"H Hassan","year":"2024","unstructured":"Hassan H, Sedky NK, Nafie MS, Mahdy NK, Fawzy IM, Fayed TW, et al. Sustainable nanomedicine: enhancement of asplatin\u2019s cytotoxicity in vitro and in vivo using green-synthesized zinc oxide nanoparticles formed via microwave-assisted and gambogic acid-mediated processes. Molecules. 2024. https:\/\/doi.org\/10.3390\/molecules29225327.","journal-title":"Molecules"},{"issue":"2","key":"2116_CR61","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2025.e42044","volume":"11","author":"BH Elwakil","year":"2025","unstructured":"Elwakil BH, Elsabrouty MH, Eskandrani A, Paudel KR, Moneer EA. Multifunctional Plumeria rubra nanoparticles: antimicrobial, antiviral, antiparasitic and anti-inflammatory activities. Heliyon. 2025;11(2):e42044. https:\/\/doi.org\/10.1016\/j.heliyon.2025.e42044.","journal-title":"Heliyon"},{"key":"2116_CR62","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpx.2024.100293","volume":"8","author":"M Said","year":"2024","unstructured":"Said M, Ali KM, Alfadhel MM, Afzal O, Aldosari BN, Alsunbul M, et al. Ocular mucoadhesive and biodegradable spanlastics loaded cationic spongy insert for enhancing and sustaining the anti-inflammatory effect of prednisolone Na phosphate; preparation, I-optimal optimization, and in-vivo evaluation. International Journal of Pharmaceutics: X. 2024;8:100293. https:\/\/doi.org\/10.1016\/j.ijpx.2024.100293.","journal-title":"International Journal of Pharmaceutics: X"},{"issue":"1","key":"2116_CR63","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1080\/10717544.2021.1872740","volume":"28","author":"S Sayed","year":"2021","unstructured":"Sayed S, Abdel-Moteleb M, Amin MM, Khowessah OM. Cubogel as potential platform for glaucoma management. Drug Deliv. 2021;28(1):293\u2013305. https:\/\/doi.org\/10.1080\/10717544.2021.1872740.","journal-title":"Drug Deliv"},{"key":"2116_CR64","doi-asserted-by":"publisher","first-page":"2921","DOI":"10.2147\/IJN.S107569","volume":"11","author":"H Kang","year":"2016","unstructured":"Kang H, Cha KH, Cho W, Park J, Park HJ, Sun BK, et al. Cyclosporine amicellar delivery system for dry eyes. Int J Nanomedicine. 2016;11:2921\u201333. https:\/\/doi.org\/10.2147\/IJN.S107569.","journal-title":"Int J Nanomedicine"},{"key":"2116_CR65","doi-asserted-by":"publisher","DOI":"10.4103\/pajo.pajo_16_22","author":"A Tripathi","year":"2022","unstructured":"Tripathi A, Agarwal R, Kharya P. Dry eye disease related to digital screen exposure in medical students. Pan Am J Ophthalmol. 2022. https:\/\/doi.org\/10.4103\/pajo.pajo_16_22.","journal-title":"Pan Am J Ophthalmol"},{"key":"2116_CR66","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2025.125193","volume":"670","author":"DA Helal","year":"2025","unstructured":"Helal DA, Osama A, El-Nabarawi MA, Teaima MH, Ibrahim Al-Samadi IE. Dual-action of clotrimazole loaded - nanosponges vaginal gel for spermicidal action and treatment of vaginal candidiasis: optimization, in-vitro, ex-vivo, and in-vivo experiments. Int J Pharm. 2025;670:125193. https:\/\/doi.org\/10.1016\/j.ijpharm.2025.125193.","journal-title":"Int J Pharm"},{"key":"2116_CR67","volume-title":"Symptoms in the pharmacy: a guide to the management of common illness","author":"A Blenkinsopp","year":"1998","unstructured":"Blenkinsopp A, Paxton P. Symptoms in the pharmacy: a guide to the management of common illness. 3rd ed. Oxford: Blackwell Science; 1998.","edition":"3"},{"key":"2116_CR68","doi-asserted-by":"publisher","DOI":"10.3390\/molecules27072326","author":"MA Kalam","year":"2022","unstructured":"Kalam MA, Iqbal M, Alshememry A, Alkholief M, Alshamsan A. Development and evaluation of chitosan nanoparticles for ocular delivery of tedizolid phosphate. Molecules. 2022. https:\/\/doi.org\/10.3390\/molecules27072326.","journal-title":"Molecules"},{"issue":"1","key":"2116_CR69","doi-asserted-by":"publisher","first-page":"2868","DOI":"10.1080\/10717544.2022.2115164","volume":"29","author":"R Abdelmonem","year":"2022","unstructured":"Abdelmonem R, Al-Samadi IEI, El Nashar RM, Jasti BR, El-Nabarawi MA. Fabrication of nanostructured lipid carriers ocugel for enhancing Loratadine used in treatment of COVID-19 related symptoms: statistical optimization, in-vitro, ex-vivo, and in-vivo studies evaluation. Drug Deliv. 2022;29(1):2868\u201382. https:\/\/doi.org\/10.1080\/10717544.2022.2115164.","journal-title":"Drug Deliv"},{"key":"2116_CR70","doi-asserted-by":"publisher","DOI":"10.1016\/j.jddst.2020.102075","author":"M Said","year":"2021","unstructured":"Said M, Aboelwafa AA, Elshafeey AH, Elsayed I. Central composite optimization of ocular mucoadhesive cubosomes for enhanced bioavailability and controlled delivery of voriconazole. J Drug Deliv Sci Technol. 2021. https:\/\/doi.org\/10.1016\/j.jddst.2020.102075.","journal-title":"J Drug Deliv Sci Technol"},{"key":"2116_CR71","doi-asserted-by":"publisher","DOI":"10.1016\/j.msec.2020.111548","volume":"119","author":"VK Rapalli","year":"2021","unstructured":"Rapalli VK, Banerjee S, Khan S, Jha PN, Gupta G, Dua K, et al. QbD-driven formulation development and evaluation of topical hydrogel containing ketoconazole loaded cubosomes. Mater Sci Eng C Mater Biol Appl. 2021;119:111548. https:\/\/doi.org\/10.1016\/j.msec.2020.111548.","journal-title":"Mater Sci Eng C Mater Biol Appl"},{"key":"2116_CR72","doi-asserted-by":"publisher","DOI":"10.1016\/j.jddst.2023.104340","author":"H Roy","year":"2023","unstructured":"Roy H, Srungarapati S, Gade NJ, Gummadi A, Marry Karunasree BK, Dakkumalla M, et al. Citicoline loaded nanoemulsion enriched with D-alpha-Tocopherol acetate and protein: formulation and in-silico study. J Drug Deliv Sci Technol. 2023. https:\/\/doi.org\/10.1016\/j.jddst.2023.104340.","journal-title":"J Drug Deliv Sci Technol"},{"issue":"1","key":"2116_CR73","doi-asserted-by":"publisher","DOI":"10.1208\/s12249-018-1225-7","volume":"20","author":"A Narala","year":"2019","unstructured":"Narala A, Guda S, Veerabrahma K. Lipid nanoemulsions of rebamipide: formulation, characterization, and in vivo evaluation of pharmacokinetic and pharmacodynamic effects. AAPS PharmSciTech. 2019;20(1):26. https:\/\/doi.org\/10.1208\/s12249-018-1225-7.","journal-title":"AAPS PharmSciTech"},{"issue":"1","key":"2116_CR74","doi-asserted-by":"publisher","first-page":"24","DOI":"10.31351\/vol28iss1pp24-36","volume":"28","author":"ZAH Radhi","year":"2019","unstructured":"Radhi ZAH, Ghareeb MM. Preparation and evaluation of rebamipide film using casting technique for local action. Iraqi J Pharm Sci. 2019;28(1):24\u201336. https:\/\/doi.org\/10.31351\/vol28iss1pp24-36.","journal-title":"Iraqi J Pharm Sci"},{"key":"2116_CR75","doi-asserted-by":"publisher","unstructured":"Niharika Girish M, K K. Solid Lipid Nanoparticles of Rebamipide: Formulation, Characterization and in Vivo Pharmacokinetic Evaluation. Int J Appl Pharm. 2022:143\u201350. https:\/\/doi.org\/10.22159\/ijap.2022v14i2.42945.","DOI":"10.22159\/ijap.2022v14i2.42945"},{"key":"2116_CR76","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics15020680","author":"AA El-Shenawy","year":"2023","unstructured":"El-Shenawy AA, Elsayed MMA, Atwa GMK, Abourehab MAS, Mohamed MS, Ghoneim MM, et al. Anti-tumor activity of orally administered gefitinib-loaded nanosized cubosomes against colon cancer. Pharmaceutics. 2023. https:\/\/doi.org\/10.3390\/pharmaceutics15020680.","journal-title":"Pharmaceutics"},{"key":"2116_CR77","doi-asserted-by":"publisher","DOI":"10.3390\/polym16162240","author":"SA El-Shahed","year":"2024","unstructured":"El-Shahed SA, Hassan DH, El-Nabarawi MA, El-Setouhy DA, Abdellatif MM. Polymeric mixed micelle-loaded hydrogel for the ocular delivery of fexofenadine for treating allergic conjunctivitis. Polymers (Basel). 2024. https:\/\/doi.org\/10.3390\/polym16162240.","journal-title":"Polymers (Basel)"},{"issue":"1","key":"2116_CR78","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-025-96739-4","volume":"15","author":"I Iftikhar","year":"2025","unstructured":"Iftikhar I, Barkat K, Badshah SF, Ashraf MU, Mehmood Y, Anjum I, et al. Formulation of pH responsive polymeric hydrogels for prolonged delivery of famciclovir with biosafety evaluation. Sci Rep. 2025;15(1):18686. https:\/\/doi.org\/10.1038\/s41598-025-96739-4.","journal-title":"Sci Rep"},{"key":"2116_CR79","doi-asserted-by":"publisher","DOI":"10.3390\/ph14111201","author":"B Gupta","year":"2021","unstructured":"Gupta B, Mishra V, Gharat S, Momin M, Omri A. Cellulosic polymers for enhancing drug bioavailability in ocular drug delivery systems. Pharmaceuticals (Basel). 2021. https:\/\/doi.org\/10.3390\/ph14111201.","journal-title":"Pharmaceuticals (Basel)"},{"issue":"12","key":"2116_CR80","doi-asserted-by":"publisher","first-page":"1539","DOI":"10.1111\/j.2042-7158.2011.01360.x","volume":"63","author":"NT Tung","year":"2011","unstructured":"Tung NT, Park CW, Oh TO, Kim JY, Ha JM, Rhee YS, et al. Formulation of solid dispersion of rebamipide evaluated in a rat model for improved bioavailability and efficacy. J Pharm Pharmacol. 2011;63(12):1539\u201347. https:\/\/doi.org\/10.1111\/j.2042-7158.2011.01360.x.","journal-title":"J Pharm Pharmacol"},{"issue":"3","key":"2116_CR81","doi-asserted-by":"publisher","first-page":"268","DOI":"10.3109\/10837450.2014.996899","volume":"21","author":"DP Medarevic","year":"2016","unstructured":"Medarevic DP, Kachrimanis K, Mitric M, Djuris J, Djuric Z, Ibric S. Dissolution rate enhancement and physicochemical characterization of carbamazepine-poloxamer solid dispersions. Pharm Dev Technol. 2016;21(3):268\u201376. https:\/\/doi.org\/10.3109\/10837450.2014.996899.","journal-title":"Pharm Dev Technol"},{"key":"2116_CR82","doi-asserted-by":"publisher","DOI":"10.3390\/colloids4040043","author":"Y Kawano","year":"2020","unstructured":"Kawano Y, Utsunomiya Y, Yokoyama F, Ishii N, Hanawa T. Preparation and evaluation of rebamipide colloidal nanoparticles obtained by cogrinding in ternary ground mixtures. Colloids and Interfaces. 2020. https:\/\/doi.org\/10.3390\/colloids4040043.","journal-title":"Colloids and Interfaces"},{"key":"2116_CR83","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2022.121686","volume":"619","author":"G Jin","year":"2022","unstructured":"Jin G, Ngo HV, Wang J, Cui JH, Cao QR, Park C, et al. Electrostatic molecular effect of differently charged surfactants on the solubilization capacity and physicochemical properties of salt-caged nanosuspensions containing pH-dependent and poorly water-soluble rebamipide. Int J Pharm. 2022;619:121686. https:\/\/doi.org\/10.1016\/j.ijpharm.2022.121686.","journal-title":"Int J Pharm"},{"issue":"3","key":"2116_CR84","doi-asserted-by":"publisher","first-page":"912","DOI":"10.1039\/c9bm01512d","volume":"8","author":"M Sun","year":"2020","unstructured":"Sun M, Deng Z, Shi F, Zhou Z, Jiang C, Xu Z, et al. Rebamipide-loaded chitosan nanoparticles accelerate prostatic wound healing by inhibiting M1 macrophage-mediated inflammation via the NF-kappaB signaling pathway. Biomater Sci. 2020;8(3):912\u201325. https:\/\/doi.org\/10.1039\/c9bm01512d.","journal-title":"Biomater Sci"},{"issue":"2","key":"2116_CR85","doi-asserted-by":"publisher","first-page":"132","DOI":"10.5530\/phm.2016.7.20","volume":"7","author":"P Kashid","year":"2016","unstructured":"Kashid P, Doijad R, Shete A, Sajane S, Bhagat A. Studies on rebamipide loaded gastroretentive alginate based mucoadhesive beads: formulation & in-vitro, in-vivo evaluation. Pharm Methods. 2016;7(2):132\u20138. https:\/\/doi.org\/10.5530\/phm.2016.7.20.","journal-title":"Pharm Methods"},{"key":"2116_CR86","doi-asserted-by":"publisher","DOI":"10.3390\/polym15071774","author":"RM Zaki","year":"2023","unstructured":"Zaki RM, El Sayeh Abou El Ela A, Almurshedi AS, Aldosari BN, Aldossari AA, Ibrahim MA. Fabrication and assessment of orodispersible tablets loaded with cubosomes for the improved anticancer activity of simvastatin against the MDA-MB-231 breast cancer cell line. Polymers (Basel). 2023. https:\/\/doi.org\/10.3390\/polym15071774.","journal-title":"Polymers (Basel)"},{"key":"2116_CR87","doi-asserted-by":"publisher","DOI":"10.1016\/j.jddst.2024.106127","author":"M Nasr","year":"2024","unstructured":"Nasr M, Kira AY, Saber S. Localized delivery of Roxadustat via cubosomes-based thermosensitive in-situ hydrogel enhances diabetic wound healing by stabilizing HIF-1\u03b1 in rats. J Drug Deliv Sci Technol. 2024. https:\/\/doi.org\/10.1016\/j.jddst.2024.106127.","journal-title":"J Drug Deliv Sci Technol"},{"key":"2116_CR88","doi-asserted-by":"publisher","DOI":"10.1016\/j.colsurfb.2021.112255","volume":"211","author":"D Modi","year":"2022","unstructured":"Modi D, Nirmal J, Warsi MH, Bhatia M, Hasan N, Kesharwani P, et al. Formulation and development of tacrolimus-gellan gum nanoformulation for treatment of dry eye disease. Colloids Surf B Biointerfaces. 2022;211:112255. https:\/\/doi.org\/10.1016\/j.colsurfb.2021.112255.","journal-title":"Colloids Surf B Biointerfaces"},{"key":"2116_CR89","doi-asserted-by":"publisher","DOI":"10.1016\/j.carbpol.2024.123164","volume":"352","author":"TY Ger","year":"2025","unstructured":"Ger TY, Yang CJ, Bui HL, Lue SJ, Yao CH, Lai JY. Alginate-functionalized nanoceria as ion-responsive eye drop formulation to treat corneal abrasion. Carbohydr Polym. 2025;352:123164. https:\/\/doi.org\/10.1016\/j.carbpol.2024.123164.","journal-title":"Carbohydr Polym"},{"key":"2116_CR90","doi-asserted-by":"publisher","DOI":"10.1016\/j.jddst.2020.101736","author":"UU Shivam","year":"2020","unstructured":"Shivam UU, Siddhi KC, Devarshi UG, Umeshkumar MU, Jayvadan KP. Nanoparticles laden in situ gel for sustained drug release after topical ocular administration. J Drug Deliv Sci Technol. 2020. https:\/\/doi.org\/10.1016\/j.jddst.2020.101736.","journal-title":"J Drug Deliv Sci Technol"},{"issue":"7","key":"2116_CR91","doi-asserted-by":"publisher","DOI":"10.1208\/s12249-024-02943-2","volume":"25","author":"SA Fouad","year":"2024","unstructured":"Fouad SA, Badr TA, Abdelbary A, Fadel M, Abdelmonem R, Jasti BR, et al. New insight for enhanced topical targeting of caffeine for effective cellulite treatment: in vitro characterization, permeation studies, and histological evaluation in rats. AAPS PharmSciTech. 2024;25(7):237. https:\/\/doi.org\/10.1208\/s12249-024-02943-2.","journal-title":"AAPS PharmSciTech"},{"issue":"1","key":"2116_CR92","doi-asserted-by":"publisher","DOI":"10.1186\/s12903-025-05755-3","volume":"25","author":"A Balat","year":"2025","unstructured":"Balat A, Gurel HG, Ordueri NE. In vitro evaluation of cytotoxicity of fixed functional appliances. BMC Oral Health. 2025;25(1):375. https:\/\/doi.org\/10.1186\/s12903-025-05755-3.","journal-title":"BMC Oral Health"},{"issue":"1","key":"2116_CR93","doi-asserted-by":"publisher","DOI":"10.1186\/s12951-024-02402-x","volume":"22","author":"B Tang","year":"2024","unstructured":"Tang B, Wang Q, Zhang G, Zhang A, Zhu L, Zhao R, et al. OCTN2- and ATB(0,+)-targeted nanoemulsions for improving ocular drug delivery. J Nanobiotechnology. 2024;22(1):130. https:\/\/doi.org\/10.1186\/s12951-024-02402-x.","journal-title":"J Nanobiotechnology"},{"issue":"11S","key":"2116_CR94","doi-asserted-by":"publisher","first-page":"S4","DOI":"10.1016\/j.ophtha.2017.07.010","volume":"124","author":"SC Pflugfelder","year":"2017","unstructured":"Pflugfelder SC, de Paiva CS. The pathophysiology of dry eye disease: what we know and future directions for research. Ophthalmology. 2017;124(11S):S4-13. https:\/\/doi.org\/10.1016\/j.ophtha.2017.07.010.","journal-title":"Ophthalmology"},{"issue":"11","key":"2116_CR95","doi-asserted-by":"publisher","first-page":"1426","DOI":"10.1016\/j.joca.2012.08.002","volume":"20","author":"SJ Moon","year":"2012","unstructured":"Moon SJ, Woo YJ, Jeong JH, Park MK, Oh HJ, Park JS, et al. Rebamipide attenuates pain severity and cartilage degeneration in a rat model of osteoarthritis by downregulating oxidative damage and catabolic activity in chondrocytes. Osteoarthritis Cartilage. 2012;20(11):1426\u201338. https:\/\/doi.org\/10.1016\/j.joca.2012.08.002.","journal-title":"Osteoarthritis Cartilage"},{"issue":"2","key":"2116_CR96","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1007\/s10787-023-01144-w","volume":"31","author":"YT Eloutify","year":"2023","unstructured":"Eloutify YT, El-Shiekh RA, Ibrahim KM, Hamed AR, Al-Karmalawy AA, Shokry AA, et al. Bioactive fraction from Plumeria obtusa L. attenuates LPS-induced acute lung injury in mice and inflammation in RAW 264.7 macrophages: LC\/QToF-MS and molecular docking. Inflammopharmacology. 2023;31(2):859\u201375. https:\/\/doi.org\/10.1007\/s10787-023-01144-w.","journal-title":"Inflammopharmacology"},{"key":"2116_CR97","doi-asserted-by":"publisher","DOI":"10.1016\/j.jddst.2025.106899","author":"S Katawale","year":"2025","unstructured":"Katawale S, Tank S, Dhaygude H, Holm R, Shah S, Shinde U, et al. Systemic delivery of sorafenib tosylate loaded LeciPlex\u00ae: a comparative assessment of nano assembly, biocompatibility, and In vivo drug disposition. J Drug Deliv Sci Technol. 2025. https:\/\/doi.org\/10.1016\/j.jddst.2025.106899.","journal-title":"J Drug Deliv Sci Technol"},{"key":"2116_CR98","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1016\/j.actbio.2019.08.035","volume":"99","author":"G Tan","year":"2019","unstructured":"Tan G, Li J, Song Y, Yu Y, Liu D, Pan W. Phenylboronic acid-tethered chondroitin sulfate-based mucoadhesive nanostructured lipid carriers for the treatment of dry eye syndrome. Acta Biomater. 2019;99:350\u201362. https:\/\/doi.org\/10.1016\/j.actbio.2019.08.035.","journal-title":"Acta Biomater"},{"key":"2116_CR99","doi-asserted-by":"publisher","DOI":"10.1002\/sstr.202400484","author":"S Ghosh","year":"2024","unstructured":"Ghosh S, Su YH, Yang CJ, Lai JY. Design of highly adhesive urchin\u2010like gold nanostructures for effective topical drug administration and symptomatic relief of corneal dryness. Small Structures. 2024. https:\/\/doi.org\/10.1002\/sstr.202400484.","journal-title":"Small Structures"},{"key":"2116_CR100","doi-asserted-by":"publisher","DOI":"10.1080\/2331205x.2017.1321869","author":"S Shah","year":"2017","unstructured":"Shah S, Badhu BP, Lavaju P, Chaudhary S, Sinha AK, Schumacher U. Efficacy of topical carboxymethyl cellulose 0.5% and cyclosporine A 0.05% in dry eye syndrome. Cogent Med. 2017. https:\/\/doi.org\/10.1080\/2331205x.2017.1321869.","journal-title":"Cogent Med"}],"container-title":["Drug Delivery and Translational Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13346-026-02116-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13346-026-02116-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13346-026-02116-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T13:38:31Z","timestamp":1776260311000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13346-026-02116-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,15]]},"references-count":100,"alternative-id":["2116"],"URL":"https:\/\/doi.org\/10.1007\/s13346-026-02116-7","relation":{},"ISSN":["2190-393X","2190-3948"],"issn-type":[{"value":"2190-393X","type":"print"},{"value":"2190-3948","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,15]]},"assertion":[{"value":"10 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}]}}